Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Eur J Clin Pharmacol ; 78(5): 781-791, 2022 May.
Artigo em Inglês | MEDLINE | ID: mdl-35171316

RESUMO

PURPOSE: Adverse drug reactions (ADRs) contribute significantly to healthcare burden. However, they are largely preventable through appropriate management processes. This narrative review aims to identify the quality indicators that should be considered for routine monitoring of processes within hospital ADR management systems. It also examines the potential reasons behind variation in ADR management practices amongst HCPs, and explores possible solutions, focusing on targeted education programmes, to improve both the quality and quantity indicators of ADR management processes. METHODS: A comprehensive literature review was conducted to explore relevant themes and topics concerning ADR management, quality indicators and educational interventions. RESULTS: Substantial variability exists in ADR management amongst healthcare professionals (HCPs) with regard to reporting rates, characteristics of ADRs reported, quality of assessment, completeness of reports and, most importantly, risk communication practices. These variable practices not only threaten patient safety but also undermine pharmacovigilance processes. To date, quality indicators to monitor ADR management practices within hospital settings remain ill-defined. Furthermore, evidence behind effective interventions, especially in the form of targeted education strategies, to improve the quality of ADR management remains limited. CONCLUSIONS: The focus of ADR management in hospitals should be to promote patient safety through comprehensive assessment, risk communication and safe prescribing. There is a need to develop a system to define, measure and monitor the quality of ADR management. Educational strategies may help improve the quality of ADR management processes.


Assuntos
Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos , Indicadores de Qualidade em Assistência à Saúde , Sistemas de Notificação de Reações Adversas a Medicamentos , Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos/epidemiologia , Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos/prevenção & controle , Hospitais , Humanos , Farmacovigilância
2.
Intern Med J ; 51(4): 591-595, 2021 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-33890379

RESUMO

Influenza vaccination is an important preventative health measure in the elderly and those with medical comorbidities. It has been shown to reduce hospitalisations, cardiovascular and respiratory complications. A significant proportion of patients admitted to general medicine are eligible for opportunistic inpatient influenza vaccination. This study explores the cost-effectiveness of such a strategy in reducing subsequent healthcare utilisation costs.


Assuntos
Vacinas contra Influenza , Influenza Humana , Idoso , Análise Custo-Benefício , Hospitalização , Humanos , Influenza Humana/epidemiologia , Influenza Humana/prevenção & controle , Pacientes Internados , Vacinação
3.
Intern Med J ; 51(2): 264-267, 2021 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-33631858

RESUMO

Rhabdomyolysis is a clinical syndrome with significant morbidity and mortality that occurs as a result of traumatic and non-traumatic aetiologies. Acute kidney injury, the need for dialysis, and death, can occur due to rhabdomyolysis. This study explores the aetiologies, clinical outcomes and associated factors for poor outcomes in a cohort of patients with rhabdomyolysis in a tertiary trauma centre in Australia.


Assuntos
Injúria Renal Aguda , Rabdomiólise , Injúria Renal Aguda/diagnóstico , Injúria Renal Aguda/epidemiologia , Injúria Renal Aguda/etiologia , Austrália/epidemiologia , Estudos de Coortes , Humanos , Estudos Retrospectivos , Rabdomiólise/diagnóstico , Rabdomiólise/epidemiologia , Rabdomiólise/terapia , Centros de Traumatologia
4.
Intern Med J ; 49(5): 662-665, 2019 05.
Artigo em Inglês | MEDLINE | ID: mdl-31083800

RESUMO

Influenza vaccination is an important preventative health measure. A significant proportion of general medical inpatients meets indications for annual inactivated influenza vaccination (IIV), as recommended by the Australian National Immunisation Programme. This study explores opportunities to provide IIV to eligible general medical inpatients and associated barriers.


Assuntos
Programas de Imunização/tendências , Vacinas contra Influenza/uso terapêutico , Influenza Humana/epidemiologia , Influenza Humana/prevenção & controle , Admissão do Paciente/tendências , Vacinação/tendências , Idoso , Idoso de 80 Anos ou mais , Austrália/epidemiologia , Estudos Transversais , Feminino , Humanos , Programas de Imunização/normas , Vacinas contra Influenza/normas , Influenza Humana/diagnóstico , Masculino , Vacinação/normas
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA